Clinical Trial Update: Vildagliptin in Older Adults With Diabetes and Mild Cognitive Impairment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating vildagliptin in older adults with diabetes and mild cognitive impairment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Vildagliptin (vildagliptin)

Snippet

Sponsor: University of Catania | Conditions: Mild Cognitive Impairment | Phase 4 | Status: COMPLETED